報道90例復發性肝癌的外科治療,討論了肝癌復發的機理及影響因素。認為肝癌術后復發的早期診斷有賴于術后AFP的監測及B超的定期復查,肝切除術仍是復發性肝癌的首選治療,術中無水酒精注射和肝動脈插管栓塞化療是提高肝癌術后長期生存的途徑。
引用本文:
李相成,王學浩,杜競輝,趙中辛,張峰,錢建民. 復發性肝癌90例的外科治療. 中國普外基礎與臨床雜志, 1997, 4(3): 150-152. doi:
復制
1. |
Belghiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg, 1991; 214∶114.
|
2. |
Zhou XD, Tang ZY, Yu YQ, et al. Surgical treatment of recurrent hepatocellular carcinoma. HepatoGastroenterol, 1993; 40∶3333Ouchim K, Matsubara S, Fukuhara K, et al. Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection Am J Surg, 1993; 16(9)∶2704Liang XH. Resection of hepatocellular carcinoma oligocentric origin recurrent and multinodular tumors. J Gastroenterol Hepatol, 1991; 6∶775Kanematsu T, Matsumata T, Takenakak,et al. Clinical management of recurrent hepatocellular carcinoma after primary resection. Br J Surg, 1988; 75∶2036Kakazu. Repeat hepatic resection for recurrent hepatocellular carcinoma. HepatoGastroenterol, 1993; 40∶3377Okazaki M. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterol, 1993; 40∶320.
|
- 1. Belghiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg, 1991; 214∶114.
- 2. Zhou XD, Tang ZY, Yu YQ, et al. Surgical treatment of recurrent hepatocellular carcinoma. HepatoGastroenterol, 1993; 40∶3333Ouchim K, Matsubara S, Fukuhara K, et al. Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection Am J Surg, 1993; 16(9)∶2704Liang XH. Resection of hepatocellular carcinoma oligocentric origin recurrent and multinodular tumors. J Gastroenterol Hepatol, 1991; 6∶775Kanematsu T, Matsumata T, Takenakak,et al. Clinical management of recurrent hepatocellular carcinoma after primary resection. Br J Surg, 1988; 75∶2036Kakazu. Repeat hepatic resection for recurrent hepatocellular carcinoma. HepatoGastroenterol, 1993; 40∶3377Okazaki M. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterol, 1993; 40∶320.